COMPANY
Clinical Phase 2
Keywords: intranasal infectious disease vaccine Respiratory Syncytial Virus Infections PIV5-vectored RSV Vaccine (BLB-201) Low Dose PIV5-vectored RSV Vaccine (BLB-201) High Dose
Location: Athens, GA · source · Nov 8, 2022
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 1/Phase 2: A Study of BLB-201 RSV Vaccine in Infants and Children source ↗
- Trial start 1: Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults source ↗
Upcoming milestones
- Dec 30, 2028 (ESTIMATED) · Phase 1/Phase 2 · A Study of BLB-201 RSV Vaccine in Infants and Children · NCT05655182
Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT05655182 | A Study of BLB-201 RSV Vaccine in Infants and Children | Phase 1/Phase 2 | Recruiting | Mar 9, 2023 | Dec 30, 2028 (estimated) |
| NCT05281263 | Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults | 1 | Completed | Jul 20, 2022 | Dec 5, 2022 (actual) |
